Order Article Reprints

Alshahrani MY, Ebrahim HA, Alqahtani SM, Bayoumy NM, Kamar SS, ShamsEldeen AM, Haidara MA, Al-Ani B, Albawardi A. Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension. Molecules. 2023; 28(6):2756. https://doi.org/10.3390/molecules28062756

Alshahrani, Mohammad Y., Hasnaa A. Ebrahim, Saeed M. Alqahtani, Nervana M. Bayoumy, Samaa S. Kamar, Asmaa M. ShamsEldeen, Mohamed A. Haidara, Bahjat Al-Ani, and Alia Albawardi. 2023. "Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension" Molecules 28, no. 6: 2756. https://doi.org/10.3390/molecules28062756

Alshahrani, M. Y., Ebrahim, H. A., Alqahtani, S. M., Bayoumy, N. M., Kamar, S. S., ShamsEldeen, A. M., Haidara, M. A., Al-Ani, B., & Albawardi, A. (2023). Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension. Molecules, 28(6), 2756. https://doi.org/10.3390/molecules28062756